retatrutide vs semaglutide Tirzepatide vs Semaglutide: The Scientific Showdown of GLP-1 Agonists (2026) Retatrutide vs Semaglutide: Comparing Weight

1,2 Initially developed as antidiabetic treatments, GLP-1 RAs and, more recently, dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have demonstrated favourable metabolic outcomes with significant and sustainable weight loss in large randomised controlled trials (RCTs) and real-world studies

This structural tweak gives semaglutide a half-life of approximately 7 days, enabling once-weekly dosing

Using sunblock to protect oneself from skin darkening due to UV radiation

The process ensures purity and precise dosing, as administration is intravenous only and should be performed by trained healthcare personnel

We've seen trends come and go, but the need for reliable, research-grade compounds remains constant